The ASCO Post
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
The ASCO Post
Mar 29, 2024, 15:23 |
Insight
Paulo G Bergerot: An outstanding RCT results at The ASCO Post
Paulo G Bergerot, Medical Oncologist at the Oncoclínicas Group (Grupo Oncoclínicas), posted on X/Twitter: "Fantastic…
Mar 16, 2024, 20:23 |
Insight
Pashtoon Kasi: ctDNA is here to stay
Pashtoon Kasi, Director for Colorectal Cancer Research at Weill Cornell Medicine, shared on LinkedIn: "Just…
Feb 20, 2024, 19:26 |
Blog
Drew Moghanaki: Hollywood's nihilistic portrayal of cancer is potentially blind to the consequences on those of us in the trenches caring for people with this disease
Drew Moghanaki, Professor, Chief of Thoracic Oncology Service at David Geffen School of Medicine at…
Feb 13, 2024, 18:37 |
Blog
How ASCO’s Regional Councils Are Having an International Impact on Patients With Cancer - The ASCO Post
The ASCO Post made the following post on X: "How ASCO’s Regional Councils Are Having…
Feb 2, 2024, 15:04 |
Blog
Sylvie Leotin: The pain I faced during my cancer motivated me to use my innovation expertise to develop solutions to improve healthcare delivery for everyone
Sylvie Leotin, Editorial Board Member at the Journal of Patient Experience, shared a post on…
Jan 31, 2024, 14:31 |
Blog
Naoto Ueno: Appreciate the opportunity to be interviewed for The ASCO Post by Jame Abraham
Naoto Ueno, Director at University of Hawai’i Cancer Center, shared a post by Jame Abraham,…
May 27, 2023, 14:22 |
Drugs
Immunotherapy/Chemotherapy Combination Prolongs Survival in Advanced Biliary Tract Cancers
In an article published by The ASCO Post, it states that "The addition of the…
May 24, 2023, 15:36 |
Drugs
FDA Approves Avapritinib for Indolent Systemic Mastocytosis
On May 22, the U.S. Food and Drug Administration (FDA) approved the tyrosine kinase inhibitor…
May 24, 2023, 15:29 |
Drugs
FDA Grants Accelerated Approval to Epcoritamab-bysp for Relapsed or Refractory B-Cell Lymphoma
In an article published by The ASCO Post, it states that "May 19, the U.S.…
All:
9
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube